Skip Header

 

12 results for author:"Moisan A."Drop in Literature Citations

Customize display Download...

Page 1 of 1

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.

Simard J., Dumont M., Moisan A.M., Gaborieau V., Malouin H., Durocher F., Chiquette J., Plante M., Avard D., Bessette P. et al.

J. Med. Genet. 44:107-121(2007) · Mapped (43)

No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families.

Moisan A.M., Fortin J., Dumont M., Samson C., Bessette P., Chiquette J., Laframboise R., Lepine J., Lesperance B., Pichette R. et al.

Genet. Test. 10:104-115(2006) · Mapped (43)

The BRCA1 COOH-terminal region acts as an RNA polymerase II carboxyl-terminal domain kinase inhibitor that modulates p21WAF1/CIP1 expression.

Moisan A., Gaudreau L.

J. Biol. Chem. 281:21119-21130(2006) · Mapped (38)

A new alternative splice variant of BRCA1 containing an additional in-frame exon.

Fortin J., Moisan A.M., Dumont M., Leblanc G., Labrie Y., Durocher F., Bessette P., Bridge P., Chiquette J., Laframboise R. et al.

Biochim. Biophys. Acta 1731:57-65(2005) · Mapped (33)

Structure of primate and rodent orthologs of the prostate cancer susceptibility gene ELAC2.

Dumont M., Frank D., Moisan A.-M., Tranchant M., Soucy P., Breton R., Labrie F., Tavtigian S.V., Simard J.

Biochim. Biophys. Acta 1679:230-247(2004) · UniProtKB (3)

BRCA1 can modulate RNA polymerase II carboxy-terminal domain phosphorylation levels.

Moisan A., Larochelle C., Guillemette B., Gaudreau L.

Mol. Cell. Biol. 24:6947-6956(2004) · Mapped (33)

BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations.

Ginolhac S.M., Gad S., Corbex M., Bressac-De-Paillerets B., Chompret A., Bignon Y.J., Peyrat J.P., Fournier J., Lasset C., Giraud S. et al.

Cancer Epidemiol. Biomarkers Prev. 12:90-95(2003) · Mapped (33)

Genome sequence of the plant pathogen Ralstonia solanacearum.

Salanoubat M., Genin S., Artiguenave F., Gouzy J., Mangenot S., Arlat M., Billault A., Brottier P., Camus J.-C., Cattolico L. et al.

Nature 415:497-502(2002) · UniProtKB (5,022)

A novel A10E homozygous mutation in the HSD3B2 gene causing severe salt-wasting 3beta-hydroxysteroid dehydrogenase deficiency in 46,XX and 46,XY French-Canadians: evaluation of gonadal function after puberty.

Alos N., Moisan A.M., Ward L., Desrochers M., Legault L., Leboeuf G., van Vliet G., Simard J.

J. Clin. Endocrinol. Metab. 85:1968-1974(2000) · UniProtKB (1)

New insight into the molecular basis of 3beta-hydroxysteroid dehydrogenase deficiency: identification of eight mutations in the HSD3B2 gene in eleven patients from seven new families and comparison of the functional properties of twenty-five mutant enzymes.

Moisan A.M., Ricketts M.L., Tardy V., Desrochers M., Mebarki F., Chaussain J.-L., Cabrol S., Raux-Demay M.C., Forest M.G., Sippell W.G. et al.

J. Clin. Endocrinol. Metab. 84:4410-4425(1999) · UniProtKB (1)

cDNA cloning and expression of an Arabidopsis GTP-binding protein of the ARF family.

Regad F., Bardet C., Tremousaygue D., Moisan A., Lescure B., Axelos M.

FEBS Lett. 316:133-136(1993) · UniProtKB (1)

An inventory of 1152 expressed sequence tags obtained by partial sequencing of cDNAs from Arabidopsis thaliana.

Hoefte H., Desprez T., Amselem J., Chiapello H., Rouze P., Caboche M., Moisan A., Jourjon M.-F., Charpenteau J.-L., Berthomieu P. et al.

Plant J. 4:1051-1061(1993) · UniProtKB (73)

Page 1 of 1